Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defensin theta 1 pseudogene 2 (DEFT1P2) is an evolutionary remnant of a gene encoding theta-defensin, a type of circular antimicrobial peptide found in some non-human primates but not expressed as a mature protein in humans due to a premature stop codon. In other primates, theta-defensins (also called retrocyclins) display potent antimicrobial and antiviral activity by disrupting microbial cell membranes and blocking viral entry, such as HIV-1. In humans, DEFT1P2 is transcribed but not translated, and its status as a pseudogene means it does not contribute to natural host defense. Experimental methods have restored function in vitro by genetic engineering or aminoglycoside-mediated read-through. The existence of functional protein in non-human primates suggests an ancestral antimicrobial function now lost in great apes and humans.
no drugs targeting the human pseudogene; retrocyclin in primates blocks pathogen entry by membrane interaction and glycoprotein binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defensin theta 1 pseudogene 2 (DEFT1P2).